Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Inv. presentation
Quarterly results
MYOGEN INC (MYOG) Create: Alert

All | News | Filings
Date FiledTypeDescription
11/17/2006 8-K Quarterly results
10/24/2006 8-K Termination of a Material Definitive Agreement
10/05/2006 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Docs: "Agreement and Plan of Merger, by and among Gilead Sciences, Inc., Mustang Merger Sub, Inc. and Myogen, Inc",
"GILEAD SCIENCES TO ACQUIRE MYOGEN, INC. FOR $2.5 BILLION"
09/25/2006 8-K Investor presentation
Docs: "Myogen, Inc. Investor and Analyst Presentation Materials"
09/18/2006 8-K Entry into a Material Definitive Agreement
08/08/2006 8-K Quarterly results
Docs: "MYOGEN REPORTS 2006 SECOND QUARTER RESULTS"
08/03/2006 8-K Investor presentation
Docs: "Myogen, Inc. Investor and Analyst Presentation Materials"
07/11/2006 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "MYOGEN ANNOUNCES EXTENSION OF DRUG DISCOVERY COLLABORATION"
06/14/2006 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Poster entitled “Effects of Darusentan Treatment on Systolic Blood Pressure Control in Patients with Resistant Hypertension.”"
05/16/2006 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Poster entitled “Darusentan Reduces 24-hour Ambulatory Blood Pressure in Patients with Resistant Hypertension.”"
05/08/2006 8-K Investor presentation
Docs: "Myogen, Inc. Investor and Analyst Presentation Materials"
05/08/2006 8-K Quarterly results
Docs: "MYOGEN REPORTS 2006 FIRST QUARTER RESULTS"
05/03/2006 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "MYOGEN REPORTS RESULTS FOR THE INTEGRATED ANALYSIS OF ARIES-1 AND ARIES-2 PIVOTAL TRIALS OF AMBRISENTAN IN"
04/11/2006 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "MYOGEN REPORTS POSITIVE TOP LINE RESULTS FOR SECOND AMBRISENTAN"
04/05/2006 8-K Regulation FD Disclosure
03/07/2006 8-K Investor presentation
Docs: "Myogen, Inc. Investor and Analyst Presentation Materials"
03/06/2006 8-K Asset disposition
Docs: "GlaxoSmithKline And Myogen Announce Pulmonary Arterial Hypertension Partnership GlaxoSmithKline to Commercialise Ambrisentan in All Territories Outside of the U.S. Myogen Receives Flolan Rights in U.S. and Will Launch Commercial Operations in Q2'06",
"MYOGEN REPORTS 2005 RESULTS"
02/27/2006 8-K Entry into a Material Definitive Agreement, Departure of Directors or Principal Officers; Election of Directors; Appointment ...
02/02/2006 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "MYOGEN ANNOUNCES SALE OF MYOGEN GMBH"
02/02/2006 8-K Investor presentation
Docs: "Myogen, Inc. Investor and Analyst Presentation Materials"
01/09/2006 8-K Investor presentation
Docs: "Myogen, Inc. Investor and Analyst Presentation Materials"
12/16/2005 8-K Entry into a Material Definitive Agreement, Departure of Directors or Principal Officers; Election of Directors; Appointment ...
Docs: "DR. JUDITH A. HEMBERGER APPOINTED TO MYOGEN BOARD OF DIRECTORS"
12/12/2005 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "MYOGEN REPORTS POSITIVE TOP LINE RESULTS FOR AMBRISENTAN PHASE 3"
11/08/2005 8-K Investor presentation
Docs: "Myogen, Inc. Investor and Analyst Presentation Materials"
11/02/2005 8-K Quarterly results
Docs: "MYOGEN REPORTS 2005 THIRD QUARTER RESULTS"
10/13/2005 8-K Entry into a Material Definitive Agreement, Other Events
10/03/2005 8-K Investor presentation
Docs: "Myogen, Inc. Investor and Analyst Presentation Materials"
09/21/2005 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "MYOGEN COMPLETES $125 MILLION PUBLIC OFFERING OF COMMON STOCK"
09/16/2005 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
Docs: "Underwriting Agreement, by and among Myogen, Inc. and Goldman, Sachs & Co. as representative of the several underwriters party thereto",
"Opinion of Cooley Godward LLP",
"MYOGEN PRICES PUBLIC OFFERING OF COMMON STOCK"
09/08/2005 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "MYOGEN ANNOUNCES PUBLIC OFFERING OF COMMON STOCK"
08/26/2005 8-K Other Events
08/18/2005 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "MYOGEN REPORTS POSITIVE RESULTS FOR DARUSENTAN PHASE 2b TRIAL IN RESISTANT HYPERTENSION"
08/04/2005 8-K Quarterly results
Docs: "MYOGEN REPORTS 2005 SECOND QUARTER RESULTS"
07/12/2005 8-K Investor presentation
Docs: "Myogen, Inc. Investor and Analyst Presentation Materials"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy